Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial - Wikidata - wikimedia - TriplyDB

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

http://www.wikidata.org/entity/Q28049690

about

Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment.Has the SPRINT trial introduced a new blood-pressure goal in hypertension?Adherence to Antihypertensive Therapy.New horizons: the management of hypertension in people with dementia.Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Exami Injurious Falls and Syncope in Older Community-Dwelling Adults Meeting Inclusion Criteria for SPRINT.Office-based simple frailty score and central blood pressure predict mild cognitive impairment in an apparently healthy Japanese population: J-SHIPP study.Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countries Declining blood pressure and intensification of blood pressure management among people over 80 years: cohort study using electronic health records.The 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of Hypertension Systolic Blood Pressure Trajectory, Frailty, and All-Cause Mortality >80 Years of Age: Cohort Study Using Electronic Health Records Outcomes of Treated Hypertension at Age 80 and Older: Cohort Analysis of 79,376 Individuals Measure accurately, Act rapidly, and Partner with patients: An intuitive and practical three-part framework to guide efforts to improve hypertension control.Vascular mineralocorticoid receptor regulates microRNA-155 to promote vasoconstriction and rising blood pressure with aging.Treatment Intensification for Hypertension in US Ambulatory Medical Care.Blood pressure control in type 2 diabetic patients.Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations.Experts Provide a Glimpse of the New Post-SPRINT Era of Hypertension.Risk Factor of Cardiovascular Disease Among Older Individuals.Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.Effect of Intensive Blood Pressure Control on Gait Speed and Mobility Limitation in Adults 75 Years or Older: A Randomized Clinical Trial.Association between Frailty and Hypertension Prevalence, Treatment, and Control in the Elderly Korean Population.Blood Pressure Targets in the Hypertensive Elderly.Blood pressure parameters are associated with all-cause and cause-specific mortality in chronic kidney disease.What should the blood pressure be in patients with a prior ischemic stroke or a transient ischemic attack?Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension.Hypertension treatment in the elderly: a SPRINT to the finish.Applying the Systolic Blood Pressure Intervention Trial Results to Older Adults.Functional Status Modifies the Association of Blood Pressure with Death in Elders: Health and Retirement Study.Effects of Intensive BP Control in CKD.Management of Hypertension With a Fixed-Dose (Single-Pill) Combination of Bisoprolol and Amlodipine.Threshold and Target for Blood Pressure Lowering in the Elderly.Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations.Management of Hypertension in the Elderly and Frail Elderly.Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.The J-shaped Curve for Blood Pressure and Cardiovascular Disease Risk: Historical Context and Recent Updates.Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012.

P2860

Q28074234-91CF524E-034A-4435-BDEF-5DF4C28781AC Q30234498-FF8229DE-F075-4995-8161-6455DCC68197 Q30234502-0294F9D8-A4CA-40AF-9A62-5E9B2141737B Q30240726-C988B08D-F257-477F-A8AE-C484DA7FA56A Q30241411-F5326E34-AE89-432B-B529-AC57FD0C52D0 Q33168252-29F600E8-7C1F-4C6E-AB9F-7A4269BE7FB1 Q33168894-F890EF15-9137-46D5-BF6C-9BB01986ECED Q33560051-857C39DE-9021-4032-9C57-E43388877B7A Q33587218-525A7E3B-4A4C-4FB1-9E5D-758B061AD20F Q33601424-CF680F52-68BD-4257-9860-AE76AB5F2CBE Q33729817-10C30C7A-0878-4943-9B9B-AE015D5E5E53 Q33803000-9282A7AB-00A0-4746-B64E-7AF293EA33AA Q33834035-8343D969-66CF-4618-B825-9B057C81924F Q36319257-27F4C809-5AC3-47AF-B9FA-CF7E36F92319 Q37277242-DB0DD670-1CB3-4622-B7A0-296D95EE293C Q37434768-772C05CC-00C8-400E-8E68-C991EC941CF7 Q37566950-53105F62-C7E7-4A7B-A568-07D614EED49B Q37578449-B5552102-C69E-4E0F-A16A-3A04E9A87656 Q37605308-ACB5E02E-CB34-44FE-82A0-29B664531BD4 Q37740348-0B3ECE03-2514-4821-BF64-991D8A7D25F3 Q38378739-F9B88D77-A3B6-4D31-A184-ACC352A39620 Q38381193-F66E4C0D-35A5-42FC-B66B-74905D01EDA8 Q38633207-ABFAF94C-E827-4E33-B0DC-BD67CFC31DC3 Q38641512-DC6CE825-B947-462C-B460-3428A9E50852 Q38656898-22523AC1-88F8-4DE5-BF40-905F2A43CD83 Q38676286-1D93E731-3527-44EA-9065-3109678F66CE Q38687593-E544FC24-5D31-4E54-8FDF-59CCBF75E18D Q38707982-CCBC6ED3-A8C7-4AED-8301-E98C44FF5977 Q38759061-07EBA43D-0EE2-4AF4-B37A-6728F9E1EFAB Q38767210-56706CD4-492B-4DAD-BFF1-8AFF64CED081 Q38901358-A712F9AA-D2B1-45FE-A05B-8BBC0C22D5FB Q38943637-D7FC5769-B98F-45F5-AA48-7D4CCE98023F Q38960658-E6C1DF79-BB35-46E5-860F-17BEE1294BC6 Q38988510-036D83B4-A094-49C1-9019-C27E6593A6BE Q39062357-42732A8B-EB4B-428B-B2D3-455CC741829B Q39127869-100F7366-16E8-46B3-8044-B2CFFF83A111 Q39166266-614166E4-E10A-44F5-99D8-17E62F27845A Q39371462-13078D5D-9845-481E-A78C-18A46F47B956 Q39413753-DDC164AF-2479-4103-A064-7E1D99E6409F Q39505601-803B30D6-9B99-44EE-83E6-0B2BBBB0B4E8

P2860

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial

http://www.wikidata.org/entity/Q28049690

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@ast

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@en

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@nl

type

label

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@ast

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@en

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@nl

prefLabel

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@ast

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@en

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@nl

P1433

Q28049690-860CC887-FDE9-48C4-8BD6-0021B0F0FC6F

P1476

Q28049690-8EFFFBCA-A429-4D54-AE10-080BB2B0334C

P2093

Q28049690-39E54EE3-0998-4CB0-B402-A8C2F74E4C5B

Q28049690-44E0E370-A301-46ED-B56D-B01C20C860B0

Q28049690-50664D32-5E8A-4BC3-A014-EA5DA7A621F9

Q28049690-5C337375-1747-4A68-9EFE-117E6C37C92F

Q28049690-5C7219A8-85BB-4F0D-851C-B2934B44450B

Q28049690-615366B0-4B6E-450B-96F0-95F4DB8BBCCF

Q28049690-64B2AE54-5BBB-4DC7-B5C6-9F7432844A52

Q28049690-6CDC2FA0-B355-4432-A4F7-4379C142AC4B

Q28049690-6F7AEF9C-7837-4EB9-97F0-AD104EFD0934

Q28049690-82950005-8424-4ABF-A37C-83043BFAB1D7

P2860

Q28049690-080D433E-1876-4F5E-B8BF-E7A8C7BE7405

Q28049690-109E73BC-356D-4245-B7E4-3B1B56350E7F

Q28049690-1B984E57-AAA9-489A-B4AA-01DB4194B315

Q28049690-1F30607C-803C-4E02-A9B0-222DE604E2FD

Q28049690-203D6C9B-EE36-4049-80C8-78D2BA21313A

Q28049690-247013F7-F7CE-4786-A695-7EBC15978487

Q28049690-2917E104-2AD2-46A4-9977-991476117C20

Q28049690-2B2BFED3-9DF5-42B0-B004-1B86A0A0A880

Q28049690-2BB7B496-A45F-421D-A2D1-5FD64CA54EB0

Q28049690-4525A688-063D-46CD-8B54-070CB7667AFE

P304

Q28049690-9D213666-6902-4134-AE5D-428247BA0F51

P31

Q28049690-2444FB7B-908B-4DDE-B1B3-89738D158D99

P3181

Q28049690-3806136B-D040-4A57-8044-74687B8BE629

P356

Q28049690-D8DC720A-C4F5-4A2A-8D67-C9720A45BD1E

P407

Q28049690-129DCC07-BABC-4D50-959E-487FCDB0439B

P433

Q28049690-D66B83AB-96F0-4512-A6E7-5956A4E4A5BD

P478

Q28049690-A52238E9-2999-4C9D-BC33-87BD1303FE8B

P50

Q28049690-2F3EC986-5CCA-4D25-B87A-66F2566DB437

Q28049690-A8FBFCD2-BF2A-485E-AB06-70F0DCD40D64

P577

Q28049690-8C761DDC-58E7-41E5-B75B-DF43FAD70501

P698

Q28049690-A18F9F74-4029-432A-B565-E99A4AFEF37F

P921

Q28049690-932A8EA0-2866-486F-8168-9DB5C8723350

P932

Q28049690-ADE08DCF-3A15-4D5C-A96E-3F52C2E360D0

P3181

P356

P1433

Journal of the American Medical Association

P1476

Intensive vs Standard Blood Pr ...... s: A Randomized Clinical Trial

@en

P2093

Amret T Hawfield

http://www.w3.org/2001/XMLSchema#string

Carlos J Rodriguez

http://www.w3.org/2001/XMLSchema#string

Christianne L Roumie

http://www.w3.org/2001/XMLSchema#string

Dalane W Kitzman

http://www.w3.org/2001/XMLSchema#string

Dan R Berlowitz

http://www.w3.org/2001/XMLSchema#string

Glenn M Chertow

http://www.w3.org/2001/XMLSchema#string

Jackson T Wright

http://www.w3.org/2001/XMLSchema#string

Jeff D Williamson

http://www.w3.org/2001/XMLSchema#string

Jeffrey Whittle

http://www.w3.org/2001/XMLSchema#string

John B Kostis

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

Evidence Supporting a Systolic Blood Pressure Goal of Less Than 150 mm Hg in Patients Aged 60 Years or Older: The Minority View

Updated national and international hypertension guidelines: a review of current recommendations

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)

Functional Status and Antihypertensive Therapy in Older Adults: A New Perspective on Old Data.

Using benefit-based tailored treatment to improve the use of antihypertensive medications.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Systolic and diastolic blood pressure, incident cardiovascular events, and death in elderly persons: the role of functional limitation in the Cardiovascular Health Study

P304

2673-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2843639

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.2016.7050

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

315

http://www.w3.org/2001/XMLSchema#string

P50

Lenore J Launer

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27195814

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4988796

http://www.w3.org/2001/XMLSchema#string